Catalyst Wire Dossier Catalyst Wire Dossier

EYSUVIS

loteprednol etabonate · Alcon Laboratories, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EYSUVIS, covering 2020-10-26 to 2020-10-26. Get the full timeline:

Most recent: FDA Approved: EYSUVIS — Original Application (ALCON LABORATORIES, INC.)

See pricing